335
Views
17
CrossRef citations to date
0
Altmetric
Articles

Work ability: a new outcome measure in rheumatoid arthritis?

, , , , , , , , , & show all
Pages 127-131 | Received 04 Jun 2009, Accepted 28 Oct 2009, Published online: 08 Jan 2010

References

  • Burton W, Morrison A, Maclean R, Ruderman E. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006;56:18–27.
  • Suurmeijer TP, Waltz M, Moum T, Guillemin F, van Sonderen FL, Briancon S, Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum 2001;45:111–21.
  • Mancuso CA, Rincon M, Sayles W, Paget SA. Psychosocial variables and fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. J Rheumatol 2006;33:1496–502.
  • Verstappen SM, Bijlsma JW, Verkleij H, Buskens E, Blaauw AA, ter Borg EJ, Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum 2004;51:488–97.
  • Han C, Smolen J, Kavanaugh A, St Clair EW, Baker D, Bala M. Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis. Arthritis Rheum 2008;59:510–14.
  • Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 2004;63:395–401.
  • Allaire S, Wolfe F, Niu J, Lavalley M, Michaud K. Work disability and its economic effect on 55–64-year-old adults with rheumatoid arthritis. Arthritis Rheum 2005;53:603–8.
  • Ilmarinen JE. Aging workers. Occup Environ Med 2001;58:546–52.
  • Weinblatt ME, Keystone EC, Furst DE, Kavanaugh AF, Chartash EK, Segurado OG. Long-term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study. Ann Rheum Dis 2006;65:753–9.
  • Torrance GW, Tugwell P, Amorosi S, Chartash E, Sengupta N. Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate. Rheumatology 2004;43:712–18.
  • Halpern MT, Cifaldi MA, Kvien TK. Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group. Ann Rheum Dis 2009;68:930–7.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
  • Balder B, Lindholm NB, Lowhagen O, Palmqvist M, Plaschke P, Tunsater A, Predictors of self-assessed work ability among subjects with recent-onset asthma. Respir Med 1998;92:729–34.
  • Walsh IA, Corral S, Franco RN, Canetti EE, Alem ME, Coury HJ. [Work ability of subjects with chronic musculoskeletal disorders], in Portuguese. Rev Saude Publica 2004;38:149–56.
  • Sluiter J, Frings-Dresen M. Quality of life and illness perception in working and sick-listed chronic RSI patients. Int Arch Occup Environ Health 2008;81:495–501.
  • de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Rheumatology 1997;36:878–83.
  • Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994;38:383–92.
  • van Veldhoven M, Broersen S. Measurement quality and validity of the ‘need for recovery scale’. Occup Environ Med 2003;60:i3–9.
  • Sluiter JK, de Croon EM, Meijman TF, Frings-Dresen MHW. Need for recovery from work-related fatigue and its role in the development and prediction of subjective health complaints. Occup Environ Med 2003;60:i62–70.
  • de Croon EM, Sluiter JK, Frings-Dresen MHW. Need for recovery after work predicts sickness absence: a 2-year prospective cohort study in truck drivers. J Psychosom Res 2003;55:331–9.
  • Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
  • van Gestel AM, Anderson JJ, van Riel PL, Boers M, Haagsma CJ, Rich B, ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol 1999;26:705–11.
  • Twisk JW. Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 2004;19:769–76.
  • Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45.
  • Allaire S, Wolfe F, Niu J, Lavalley MP. Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis Rheum 2008;59:474–80.
  • de Croon EM, Sluiter JK, Nijssen TF, Kammeijer M, Dijkmans BA, Lankhorst GJ, Work ability of Dutch employees with rheumatoid arthritis. Scand J Rheumatol 2005;34:277–83.
  • de Boer AGEM, Verbeek JHAM, Spelten ER, Uitterhoeve ALJ, Ansink AC, de Reijke TM, Work ability and return-to-work in cancer patients. Br J Cancer 2008;98:1342–7.
  • Kimel M, Cifaldi M, Chen N, Revicki D. Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. J Rheumatol 2008;35:206–15.
  • Spilker B. Introduction. In: Spilker B, editor. Quality of life assessments in clinical trials. New York: Raven Press 1990:3–9.
  • Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 2006;45:885–9.
  • Katz PP. The stresses of rheumatoid arthritis: appraisals of perceived impact and coping efficacy. Arthritis Care Res 1998;11:9–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.